Literature DB >> 28398323

Nature Biotechnology's academic spinouts of 2016.

Aaron Bouchie, Laura DeFrancesco1, Cormac Sheridan, Sarah Webb.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28398323     DOI： 10.1038/nbt.3847

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  24 in total

1.  CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.

Authors:  Siddhartha Jaiswal; Catriona H M Jamieson; Wendy W Pang; Christopher Y Park; Mark P Chao; Ravindra Majeti; David Traver; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

2.  DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation.

Authors:  Georg E Winter; Dennis L Buckley; Joshiawa Paulk; Justin M Roberts; Amanda Souza; Sirano Dhe-Paganon; James E Bradner
Journal:  Science       Date:  2015-05-21       Impact factor: 47.728

3.  The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Authors:  Stephen B Willingham; Jens-Peter Volkmer; Andrew J Gentles; Debashis Sahoo; Piero Dalerba; Siddhartha S Mitra; Jian Wang; Humberto Contreras-Trujillo; Robin Martin; Justin D Cohen; Patricia Lovelace; Ferenc A Scheeren; Mark P Chao; Kipp Weiskopf; Chad Tang; Anne Kathrin Volkmer; Tejaswitha J Naik; Theresa A Storm; Adriane R Mosley; Badreddin Edris; Seraina M Schmid; Chris K Sun; Mei-Sze Chua; Oihana Murillo; Pradeep Rajendran; Adriel C Cha; Robert K Chin; Dongkyoon Kim; Maddalena Adorno; Tal Raveh; Diane Tseng; Siddhartha Jaiswal; Per Øyvind Enger; Gary K Steinberg; Gordon Li; Samuel K So; Ravindra Majeti; Griffith R Harsh; Matt van de Rijn; Nelson N H Teng; John B Sunwoo; Ash A Alizadeh; Michael F Clarke; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

4.  The prognostic landscape of genes and infiltrating immune cells across human cancers.

Authors:  Andrew J Gentles; Aaron M Newman; Chih Long Liu; Scott V Bratman; Weiguo Feng; Dongkyoon Kim; Viswam S Nair; Yue Xu; Amanda Khuong; Chuong D Hoang; Maximilian Diehn; Robert B West; Sylvia K Plevritis; Ash A Alizadeh
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

5.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.

Authors:  Timothy R Sampson; Justine W Debelius; Taren Thron; Stefan Janssen; Gauri G Shastri; Zehra Esra Ilhan; Collin Challis; Catherine E Schretter; Sandra Rocha; Viviana Gradinaru; Marie-Francoise Chesselet; Ali Keshavarzian; Kathleen M Shannon; Rosa Krajmalnik-Brown; Pernilla Wittung-Stafshede; Rob Knight; Sarkis K Mazmanian
Journal:  Cell       Date:  2016-12-01       Impact factor: 41.582

Review 6.  What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

Authors:  Jean-Jacques Fournié; Hélène Sicard; Mary Poupot; Christine Bezombes; Amandine Blanc; François Romagné; Loic Ysebaert; Guy Laurent
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

7.  CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

Authors:  Ravindra Majeti; Mark P Chao; Ash A Alizadeh; Wendy W Pang; Siddhartha Jaiswal; Kenneth D Gibbs; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

8.  Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.

Authors:  Gerald S Horan; Susan Wood; Victor Ona; Dan Jun Li; Matvey E Lukashev; Paul H Weinreb; Kenneth J Simon; Kyungmin Hahm; Normand E Allaire; Nicola J Rinaldi; Jaya Goyal; Carol A Feghali-Bostwick; Eric L Matteson; Carl O'Hara; Robert Lafyatis; Gerald S Davis; Xiaozhu Huang; Dean Sheppard; Shelia M Violette
Journal:  Am J Respir Crit Care Med       Date:  2007-10-04       Impact factor: 21.405

9.  Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Authors:  Stephen K Horrigan
Journal:  Elife       Date:  2017-01-19       Impact factor: 8.140

10.  RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor.

Authors:  Zsolt Sebestyen; Wouter Scheper; Anna Vyborova; Siyi Gu; Zuzana Rychnavska; Marleen Schiffler; Astrid Cleven; Coraline Chéneau; Martje van Noorden; Cassie-Marie Peigné; Daniel Olive; Robert Jan Lebbink; Rimke Oostvogels; Tuna Mutis; Gerrit Jan Schuurhuis; Erin J Adams; Emmanuel Scotet; Jürgen Kuball
Journal:  Cell Rep       Date:  2016-05-19       Impact factor: 9.423
View more
  3 in total

1.  Erratum: Nature Biotechnology's academic spinouts of 2016.

Authors:  Aaron Bouchie; Laura DeFrancesco; Cormac Sheridan; Sarah Webb
Journal:  Nat Biotechnol       Date:  2017-08-08       Impact factor: 54.908

2.  CD47 checkpoint data supercharge Stanford spinout IPO.

Authors:  Elie Dolgin
Journal:  Nat Biotechnol       Date:  2018-08-06       Impact factor: 54.908

3.  γ9δ2T cell diversity and the receptor interface with tumor cells.

Authors:  Anna Vyborova; Dennis X Beringer; Domenico Fasci; Froso Karaiskaki; Eline van Diest; Lovro Kramer; Aram de Haas; Jasper Sanders; Anke Janssen; Trudy Straetemans; Daniel Olive; Jeanette Leusen; Lola Boutin; Steven Nedellec; Samantha L Schwartz; Michael J Wester; Keith A Lidke; Emmanuel Scotet; Diane S Lidke; Albert Jr Heck; Zsolt Sebestyen; Jürgen Kuball
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.